NCDP NICODROPS (Other OTC:NCDP.PK) Worth a look, as this is a small co that has recently had major news - and looks on track to be a Major player in the stop-smoking market...
Nicodrops, Inc. developer of the world's first drug-free, non-nicotine smoking cessation lozenge, announced today it has formally received approval from the Canadian Food and Drug Administration for their smoking cessation lozenge. The Canadian FDA Approval Drug Identification Number (DIN) 00245097 was issued through the Therapeutic Products Directorate of the Health Canada, FDA. The DIN number now permits Nicodrops to sell its products in the Canadian market.
the potential market for this product is over a Billion US $
In 1999, SmithKline Beecham Consumer Healthcare's combined U.S. sales of Nicorette and NicoDerm CQ reached $570 million. The 1999 [Philippe Boucher's Rendez-vous with Leslie Ashburn, Communications Supervisor for GlaxoSmithKline, 1/29/01].
and that's just from one company :-) doing biz in US.
Unfortionately thie stock is nominated for
"Stock Dump of 2004" Biggest Dumpers Award. |